Pharmaceutical laboratories utilize these tools to characterize drug-protein binding sites, identify off-target effects, and elucidate the mechanisms of action for novel therapeutic candidates. By enabling the capture of transient or low-affinity interactions that might otherwise be missed, these reagents provide critical structural insights at biological interfaces. Many of these probes are also available as stable isotope labelled compounds, which facilitate precise quantitative analysis through mass spectrometry, allowing researchers to accurately detect and validate specific target proteins within complex biological systems during early-stage development.